Frequency of hospitalizations due to hemolytic uremic syndrome in children from 0 to 14 years of age in Peru, period 2015 to 2022

Introduction. There are limited epidemiological reports of hemolytic uremic syndrome (HUS) in Latin America. Objective. To describe the frequency and characteristics of hospitalizations due to HUS in children aged 0 to 14 years. Methods. Descriptive study of secondary analysis was performed with dat...

ver descrição completa

Detalhes bibliográficos
Autores: Atamari-Anahui, Noé, Cabello-Coca, Stephanie, Alvarado-Gamarra, Giancarlo, Apeña-Cabrera, Carla Lisette
Tipo de documento: artigo
Estado:Versão publicada
Data de publicação:2023
País:Perú
Recursos:Universidad Nacional Mayor de San Marcos
Repositório:Revistas - Universidad Nacional Mayor de San Marcos
Idioma:espanhol
OAI Identifier:oai:revistasinvestigacion.unmsm.edu.pe:article/25083
Acesso em linha:https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/25083
Access Level:Acceso aberto
Palavra-chave:Síndrome Urémico Hemolítico
Epidemiologia
Niño
Perú
Hemolytic uremic syndrome
Epidemiology
Child
Peru
Descrição
Resumo:Introduction. There are limited epidemiological reports of hemolytic uremic syndrome (HUS) in Latin America. Objective. To describe the frequency and characteristics of hospitalizations due to HUS in children aged 0 to 14 years. Methods. Descriptive study of secondary analysis was performed with data on hospitalizations due to HUS from healthcare institutions from Peru, 2015-2022. Results. Two hundred twenty-eight hospitalizations were registered, 52.2% were male, 88.6% were under five years old, and 11% were under one year old. The departments with more hospitalizations were Lima (133 cases) and Arequipa (46 cases). The institutions of the Ministry of Health (MINSA) and Social Security (EsSalud) reported 42.5% and 27.6% of hospitalizations. From 2015 to 2022, the incidence ranged from 0.42 to 1.13 cases/100,000 children under five years of age. Conclusions. Hospitalizations due to HUS were more frequent in children under five years of age and MINSA institutions.